Published in BMC Gastroenterol on January 11, 2006
Embolization of a large, symptomatic splenic artery pseudoaneurysm. Pol J Radiol (2014) 0.96
Endovascular intervention for management of pancreatitis-related bleeding: a retrospective analysis of thirty-seven patients at a single institution. Diagn Interv Radiol (2015) 0.93
Peripancreatic pseudoaneurysms: a management-based classification system. Surg Endosc (2014) 0.90
Combined percutaneous thrombin injection and endovascular treatment of gastroduodenal artery pseudoaneurysm (PAGD): case report. Emerg Radiol (2007) 0.90
Vascular complications of pancreatitis: role of interventional therapy. Korean J Radiol (2012) 0.89
Management of chronic pancreatitis complicated with a bleeding pseudoaneurysm. World J Gastroenterol (2014) 0.88
Gastrointestinal bleeding complication of gastric fistula after sleeve gastrectomy: consider pseudoaneurysms. Surg Endosc (2013) 0.81
Ruptured pancreaticoduodenal artery pseudoaneurysm with chronic pancreatitis presenting as recurrent upper gastrointestinal bleeding. Dig Dis Sci (2007) 0.79
Spontaneous bleeding in pancreatitis treated by transcatheter arterial coil embolization: a retrospective study. PLoS One (2013) 0.77
Hematochezia From Splenic Arterial Pseudoaneurysm Ruptured Into Pancreatic Pseudocyst Coexisting With Fistula to the Colon: A Case Report and Literature Review. Gastroenterology Res (2014) 0.75
Successful Post-Pancreatitis Pseudoaneurysm Coagulation by Percutaneous Computed Tomography (CT)-Guided Thrombin Injection. Pol J Radiol (2017) 0.75
Mediastinal Pseudocyst: Varied Presentations and Management-Experience from a Tertiary Referral Care Centre in India. HPB Surg (2017) 0.75
Hemorrhagic Pseudocyst of Pancreas Treated with Coil Embolization of Gastroduodenal Artery: A Case Report and Review of Literature. Case Rep Surg (2015) 0.75
Complete remission of pancreatic pseudoaneurysm rupture with arterial embolization in a patient with poor risk for surgery: a case report. Case Rep Gastroenterol (2012) 0.75
Successful resolution of a hemorrhagic pancreatic pseudocyst ruptured into the stomach complicating obstructive pancreatitis due to pancreatic cancer: a case report. World J Surg Oncol (2016) 0.75
Hepatic artery pseudoaneurysm with extrahepatic biliary obstruction. Ann Vasc Dis (2012) 0.75
Bleeding pseudocysts and pseudoaneurysms in chronic pancreatitis. Br J Surg (1991) 2.96
Management of bleeding pseudoaneurysms in patients with pancreatitis. Br J Surg (1999) 1.92
Management and outcome of hemorrhage due to arterial pseudoaneurysms in pancreatitis. Surgery (2005) 1.85
Reduced mortality from bleeding pseudocysts and pseudoaneurysms caused by pancreatitis. Arch Surg (1983) 1.83
The natural history of pancreatic pseudocysts documented by computed tomography. Surg Gynecol Obstet (1990) 1.83
Timing of surgical drainage for pancreatic pseudocyst. Clinical and chemical criteria. Ann Surg (1985) 1.61
Arterial complications of pancreatitis: diagnostic and therapeutic role of radiology. Pancreas (1993) 1.61
Hemorrhagic complications of pancreatitis: radiologic evaluation with emphasis on CT imaging. Pancreatology (2001) 1.59
Revised classification of pancreatitis. Report of the Second International Symposium on the Classification of Pancreatitis in Marseille, France, March 28-30, 1984. Gastroenterology (1985) 1.45
Arterial embolization for bleeding pseudocysts complicating chronic pancreatitis. Arch Surg (1997) 1.41
Potentially fatal bleeding in acute pancreatitis: pathophysiology, prevention, and treatment. Pancreas (2003) 1.28
Systematic appraisal of the management of the major vascular complications of pancreatitis. Am J Surg (2005) 1.22
Pseudocysts and pseudoaneurysms: surgical strategy. Pancreas (1995) 1.20
Major hemorrhage from pseudocysts and pseudoaneurysms caused by chronic pancreatitis: surgical therapy. World J Surg (1991) 1.05
Evidence for a central role for selective mesenteric angiography in the management of the major vascular complications of pancreatitis. Am J Surg (2003) 0.98
Multidisciplinary approach to pseudoaneurysms complicating pancreatic pseudocysts. Impact of pretreatment diagnosis. Arch Surg (1996) 0.96
Prevalence and treatment of bleeding complications in chronic pancreatitis. Langenbecks Arch Surg (2004) 0.89
Acute hemorrhage in chronic pancreatitis: diagnosis and treatment options including superselective microcoil embolization. Pancreas (1999) 0.83
Diagnostic evaluation and aggressive surgical approach in bleeding pseudoaneurysms associated with pancreatic pseudocysts. Scand J Gastroenterol (1991) 0.82
Aggressive resection is indicated for cecal diverticulitis. Am J Surg (2003) 2.17
Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins. J Clin Invest (2003) 1.71
Clinical and ultrasonographic characteristics of breast metastases from extramammary malignancies. Am Surg (2004) 1.70
Cell surface-binding motifs of L2 that facilitate papillomavirus infection. J Virol (2003) 1.68
Development of a DNA vaccine targeting human papillomavirus type 16 oncoprotein E6. J Virol (2004) 1.66
TG13 guidelines for diagnosis and severity grading of acute cholangitis (with videos). J Hepatobiliary Pancreat Sci (2013) 1.66
Aggressive surgical approach for patients with T4 gastric carcinoma: promise or myth? Ann Surg Oncol (2011) 1.65
Encapsulation is a significant prognostic factor for better outcome in large hepatocellular carcinoma. J Surg Oncol (2012) 1.63
A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression. Nat Med (2005) 1.61
Predictors of long-term disease-free survival after resection of hepatocellular carcinoma: two decades of experience at Chang Gung Memorial Hospital. Ann Surg Oncol (2003) 1.60
Diagnostic criteria and severity assessment of acute cholangitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg (2007) 1.58
Adverse outcomes in patients with postoperative ascites after liver resection for hepatocellular carcinoma. World J Surg (2012) 1.56
Comparison of the CD8+ T cell responses and antitumor effects generated by DNA vaccine administered through gene gun, biojector, and syringe. Vaccine (2003) 1.56
Osteonecrosis of the tibia associated with imatinib in metastatic GI stromal tumor. J Clin Oncol (2013) 1.52
Insular carcinoma: infrequent subtype of thyroid cancer with aggressive clinical course. World J Surg (2004) 1.52
Enhancing DNA vaccine potency by modifying the properties of antigen-presenting cells. Expert Rev Vaccines (2007) 1.50
New diagnostic criteria and severity assessment of acute cholecystitis in revised Tokyo Guidelines. J Hepatobiliary Pancreat Sci (2012) 1.49
Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis. J Surg Oncol (2002) 1.47
Epigallocatechin-3-gallate enhances CD8+ T cell-mediated antitumor immunity induced by DNA vaccination. Cancer Res (2007) 1.43
Flowcharts for the diagnosis and treatment of acute cholangitis and cholecystitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg (2007) 1.43
Surgical treatment of thyroid cancers with concurrent Graves disease. Ann Surg Oncol (2004) 1.43
Lifestyle risk factors for intrahepatic stone: findings from a case-control study in an endemic area, Taiwan. J Gastroenterol Hepatol (2007) 1.41
Thioacetamide-induced intestinal-type cholangiocarcinoma in rat: an animal model recapitulating the multi-stage progression of human cholangiocarcinoma. Carcinogenesis (2003) 1.40
PIK3CA exon 20 mutation is independently associated with a poor prognosis in breast cancer patients. Ann Surg Oncol (2008) 1.40
Ectopic expression of vascular cell adhesion molecule-1 as a new mechanism for tumor immune evasion. Cancer Res (2007) 1.39
Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery. Vaccine (2009) 1.38
Primary angiosarcoma of the spleen. J Surg Oncol (2005) 1.37
Successful laparoscopic management for cholecystoenteric fistula. World J Gastroenterol (2006) 1.36
Cholangiographic spectrum of intraductal papillary mucinous neoplasm of the bile ducts. Ann Surg (2006) 1.36
Hepatic resection and prognosis for patients with hepatocellular carcinoma larger than 10 cm: two decades of experience at Chang Gung memorial hospital. Ann Surg Oncol (2003) 1.34
Modification of professional antigen-presenting cells with small interfering RNA in vivo to enhance cancer vaccine potency. Cancer Res (2005) 1.32
Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus. J Virol (2004) 1.30
Pretreatment with cisplatin enhances E7-specific CD8+ T-Cell-mediated antitumor immunity induced by DNA vaccination. Clin Cancer Res (2008) 1.29
Hepatic resection for hepatocellular carcinoma with obstructive jaundice due to biliary tumor thrombi. World J Surg (2004) 1.28
Chemotherapy acts as an adjuvant to convert the tumor microenvironment into a highly permissive state for vaccination-induced antitumor immunity. Cancer Res (2013) 1.27
Enhancement of DNA vaccine potency by coadministration of a tumor antigen gene and DNA encoding serine protease inhibitor-6. Cancer Res (2004) 1.24
New diagnostic criteria and severity assessment of acute cholangitis in revised Tokyo Guidelines. J Hepatobiliary Pancreat Sci (2012) 1.23
Monitoring the trafficking of adoptively transferred antigen- specific CD8-positive T cells in vivo, using noninvasive luminescence imaging. Hum Gene Ther (2007) 1.23
Activation of Akt as a mechanism for tumor immune evasion. Mol Ther (2008) 1.22
Postsurgical infections are reduced with specialized nutrition support. World J Surg (2006) 1.22
Enhancing DNA vaccine potency by combining a strategy to prolong dendritic cell life with intracellular targeting strategies. J Immunol (2003) 1.21
Antimicrobial therapy for acute cholangitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg (2007) 1.19
Vaccination of advanced hepatocellular carcinoma patients with tumor lysate-pulsed dendritic cells: a clinical trial. J Immunother (2005) 1.19
Usefulness of multidetector computed tomography for the initial assessment of blunt abdominal trauma patients. World J Surg (2006) 1.18
Immunotherapy for cervical cancer: Research status and clinical potential. BioDrugs (2010) 1.18
Cancer immunotherapy using Sindbis virus replicon particles encoding a VP22-antigen fusion. Hum Gene Ther (2002) 1.17
Symptomatic adult annular pancreas. J Clin Gastroenterol (2003) 1.17
Detection of rare mutant K-ras DNA in a single-tube reaction using peptide nucleic acid as both PCR clamp and sensor probe. Nucleic Acids Res (2006) 1.16
Adenosquamous/squamous cell carcinoma of the gallbladder. J Surg Oncol (2007) 1.16
Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: before the era of imatinib mesylate. BMC Gastroenterol (2006) 1.14
Clinicopathological analysis of cystic duct carcinoma. Hepatogastroenterology (2005) 1.13
Clinicopathologic study of node-negative advanced gastric cancer and analysis of factors predicting its recurrence and prognosis. Am J Surg (2012) 1.13
Generation and characterization of a preventive and therapeutic HPV DNA vaccine. Vaccine (2007) 1.12
Therapeutic HPV DNA vaccines. Immunol Res (2010) 1.12
Splenic angiosarcoma metastasis to small bowel presented with gastrointestinal bleeding. World J Gastroenterol (2005) 1.12
Kinase mutations and imatinib mesylate response for 64 Taiwanese with advanced GIST: preliminary experience from Chang Gung Memorial Hospital. Ann Surg Oncol (2006) 1.11
DNA vaccines delivered by human papillomavirus pseudovirions as a promising approach for generating antigen-specific CD8+ T cell immunity. Cell Biosci (2011) 1.11
Correct diagnosis and successful treatment for pericardial effusion due to toothpick injury: a case report and literature review. World J Gastroenterol (2007) 1.10
Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine. Cancer Immunol Immunother (2012) 1.10
Hepatic resection of the intraductal papillary type of peripheral cholangiocarcinoma. Ann Surg Oncol (2004) 1.09
Aberrant expression of CDX2 is closely related to the intestinal metaplasia and MUC2 expression in intraductal papillary neoplasm of the liver in hepatolithiasis. Lab Invest (2004) 1.09
Perforation through small bowel malignant tumors. J Gastrointest Surg (2005) 1.08
Intradermal administration of DNA vaccines combining a strategy to bypass antigen processing with a strategy to prolong dendritic cell survival enhances DNA vaccine potency. Vaccine (2007) 1.07
Intraoperative ultrasonographically guided excisional biopsy or vacuum-assisted core needle biopsy for nonpalpable breast lesions. Ann Surg (2003) 1.06
Resectable gastric cancer: operative mortality and survival analysis. Chang Gung Med J (2002) 1.05
Adenosquamous carcinoma of the pancreas. Digestion (2005) 1.05